Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RFA Medical was a medical technology company focused on the development of radiofrequency (RF) ablation systems specifically designed for the treatment of chronic pain. The company's primary product was the G4 Radiofrequency Generator, a sophisticated system used by clinicians to perform minimally invasive procedures that disrupt pain signals from nerves. By utilizing radiofrequency energy to create heat lesions on targeted nerves, the technology provided long-term relief for patients suffering from chronic back and neck pain. RFA Medical was acquired by Boston Scientific in 2008 to bolster its Neuromodulation and Pain Management portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RFA Medical.